⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1827780 | 0.57 | — | — | |
| SCHEMBL5497166 | 0.56 | — | — | |
| SCHEMBL17333027 | 0.55 | — | — | |
| SCHEMBL6297732 | 0.55 | — | — | |
| SCHEMBL4554724 | 0.53 | — | — | |
| SCHEMBL4261904 | 0.51 | — | — | |
| SCHEMBL6653526 | 0.49 | — | — | |
| SCHEMBL13078908 | 0.36 | — | — | |
| SCHEMBL108867 | 0.32 | — | — | |
| SCHEMBL320609 | 0.32 | MEN1 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005103015-A1 | TRIAZINE COMPOUNDS AND THEIR ANALOGS, COMPOSITIONS, AND METHODS | REDDY US THERAPEUTICS, INC. (US) | 2005-11-03 | — | — | WO | claimed |
| WO-2023157876-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2023-08-24 | — | — | WO | disclosed |
| WO-2023068085-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, LIQUID CRYSTAL DISPLAY ELEMENT, AND COMPOUND | 日産化学株式会社 | 2023-04-27 | — | — | WO | disclosed |
| WO-2023068084-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, LIQUID CRYSTAL DISPLAY ELEMENT, COMPOUND AND POLYMER | 日産化学株式会社 | 2023-04-27 | — | — | WO | disclosed |
| EP-3817736-A1 | PIKFYVE INHIBITORS | Mayo Foundation for Medical Education and Research (US) | 2021-05-12 | — | — | EP | disclosed |
| US-20160093413-A1 | ELECTROCONDUCTIVE COMPOSITION, ELECTRICAL CONDUCTOR, LAMINATE AND METHOD FOR PRODUCING SAME, ELECTROCONDUCTIVE FILM, AND SOLID ELECTROLYTE CONDENSER | MITSUBISHI RAYON CO., LTD. (JP) | 2016-03-31 | — | — | US | disclosed |
| CN-105392846-A | Electroconductive composition, electrical conductor, laminate and method for producing same, electroconductive film, and solid electrolyte capacitor | MITSUBISHI RAYON CO | 2016-03-09 | — | — | CN | disclosed |
| EP-2800743-A1 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | Agios Pharmaceuticals, Inc. (US) | 2014-11-12 | — | — | EP | disclosed |
| WO-2013102431-A1 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS, INC. (US) | 2013-07-11 | — | — | WO | disclosed |
| EP-1786415-A1 | METABOLISM-MODULATING AGENTS AND USES THEREFOR | THE UNIVERSITY OF QUEENSLAND (AU) | 2007-05-23 | — | — | EP | disclosed |
| WO-2006017896-A1 | METABOLISM-MODULATING AGENTS AND USES THEREFOR | THE UNIVERSITY OF QUEENSLAND (AU) | 2006-02-23 | — | — | WO | disclosed |
| US-4931487-A | Chain extenders for polyurethanes | DOW CHEMICAL COMPANY | 1990-06-05 | — | — | US | disclosed |